Oramed Pharmaceuticals
ORMP
#9090
Rank
S$0.15 B
Marketcap
S$3.92
Share price
4.66%
Change (1 day)
16.43%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2025 : S$0.12 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has S$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.19 B-9.86%
2023-12-31S$0.21 B2.52%
2022-12-31S$0.20 B
2021-08-31S$0.12 B133.05%
2020-08-31S$54.28 M21.19%
2019-08-31S$44.79 M7.11%
2018-08-31S$41.81 M53.28%
2017-08-31S$27.28 M-35.41%
2016-08-31S$42.23 M73.88%
2015-08-31S$24.29 M-8.66%
2014-08-31S$26.59 M146.13%
2013-08-31S$10.8 M69.43%
2012-08-31S$6.37 M179.19%
2011-08-31S$2.28 M40.54%
2010-08-31S$1.62 M-58.59%
2009-08-31S$3.92 M-44.86%
2008-08-31S$7.11 M143.58%
2007-08-31S$2.92 M954.17%
2006-08-31S$0.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$0.54 B 334.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$6.61 B 5,131.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$13.49 B 10,571.74%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
S$0.11 B-12.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
S$0.14 B 18.39%๐Ÿ‡บ๐Ÿ‡ธ USA